Intranasal corticosteroids in allergic rhinitis in COVID-19 infected patients: An ARIA-EAACI statement

dc.contributor.author	Bousquet, J; Akdis, CA; Jutel, M; Bachert, C; Klimek, L; Agache, I; Ansotegui, IJ; Bedbrook, A; Bosnic-Anticevich, S; Canonica, GW; Chivato, T; Cruz, AA; Czarlewski, W; Del Giacco, S; Du, H; Fonseca, JA; Gao, YD; Haahtela, T; Hoffmann-Sommergruber, K; Ivancevich, JC; Khaltaev, N; Knol, EF; Kuna, P; Larenas-Linnemann, D; Mullol, J; Naclerio, R; Ohta, K; Okamoto, Y; O'Mahony, L; Onorato, GL; Papadopoulos, NG; Pfaar, O; Samolinski, B; Schwarze, J; Toppila-Salmi, S; Ventura, MT; Valiulis, A; Yorgancioglu, A; Zuberbier, T; Pawankar, R
dc.date.accessioned	2023-03-02T06:40:06Z
dc.date.available	2023-03-02T06:40:06Z
dc.date.issued	OCT
dc.date.issued	2020
dc.identifier.uri	http://hdl.handle.net/20.500.12481/14440
dc.title	Intranasal corticosteroids in allergic rhinitis in COVID-19 infected patients: An ARIA-EAACI statement
dc.title.alternative	ALLERGY
dc.identifier.DOI-ID	10.1111/all.14302
dc.identifier.volume	75
dc.identifier.issue	10
dc.identifier.startpage	2440
dc.identifier.endpage	2444
dc.identifier.issn/e-issn	0105-4538
dc.identifier.issn/e-issn	1398-9995

Files in this item

Files	Size	Format	View
There are no files associated with this item.